About: Effect of mannan oligosaccharides supplemented via milk replacer on the immune status and growth of calves     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
Description
  • The study included 366 calves from 2 to 10 weeks of age, divided into four groups: C, T1, T2, and T3, given milk replacer with 0, 100, 500 and 2000 ppm Safmannan (Lesaffre Feed Additives, France), respectively. In Weeks 0, 4 and 8, the calves were weighed, and 24 calves from each group were withdrawn blood to determine levels of immunoglobulines, total protein, urea. No significant difference was observed between the treatments in the growth. Overall mean initial immunoglobulin level (n=96) was 20.593 g/l. In Week 4, immunoglobulin levels were 25.280 g/L, 26.539 g/L, 25.247 g/L and 27.468 g/L in C, T1, T2 and T3, respectively. In T3 it was significantly higher than in Control, (P lt; 0.05). A tendency was observed towards an improvement of the immune status in the calves given the highest dose of MOS.
  • The study included 366 calves from 2 to 10 weeks of age, divided into four groups: C, T1, T2, and T3, given milk replacer with 0, 100, 500 and 2000 ppm Safmannan (Lesaffre Feed Additives, France), respectively. In Weeks 0, 4 and 8, the calves were weighed, and 24 calves from each group were withdrawn blood to determine levels of immunoglobulines, total protein, urea. No significant difference was observed between the treatments in the growth. Overall mean initial immunoglobulin level (n=96) was 20.593 g/l. In Week 4, immunoglobulin levels were 25.280 g/L, 26.539 g/L, 25.247 g/L and 27.468 g/L in C, T1, T2 and T3, respectively. In T3 it was significantly higher than in Control, (P lt; 0.05). A tendency was observed towards an improvement of the immune status in the calves given the highest dose of MOS. (en)
  • Studie zahrnovala 366 telat of 2 do 10 týdnů věku, rozdělených do 4 skupin. Skupina kontrolní (C) dostávala mléčnou náhražku a startérovou krmnou směs, pokusné skupiny (T1, T2 a T3) dostávaly přípravek Safmannan (Lesaffre Feed Additives, Francie) v dávkách 100, 500 a 2000 ppm. Telata byla vážena na počátku, ve čtvrtém týdnu a na konci (v 8. týdnu pokusu. V den vážení byla 24 telatům z každé skupiny odebrána krev a byly stanoveny hladiny imunoglobulinů a biochemické parametry. Průměrná hladina imunoglobulinů u všech telat (n=96) na počátku pokusu byla 20,593 g/l. Ve 4. týdnu byly hladiny imunoglobulinů 25,280 g/l v kontrolní skupině, 26,539 g/l ve skupině T1, 25,247 g/l ve skupině C2 a 27,468 g/l ve skupině C3. Skupina C3 (2000 ppm Safmannan) vykazovala průkazně vyšší hladiny imunoglobulinů než skupina kontrolní (P lt; 0.05). Nebyly pozorovány statisticky významné rozdíly v užitkovosti telat mezi skupinami. (cs)
Title
  • Effect of mannan oligosaccharides supplemented via milk replacer on the immune status and growth of calves
  • Effect of mannan oligosaccharides supplemented via milk replacer on the immune status and growth of calves (en)
  • Vliv oligosacharidů mannanů podávaných v mléčné náhražce na imunitu a užitkovost telat (cs)
skos:prefLabel
  • Effect of mannan oligosaccharides supplemented via milk replacer on the immune status and growth of calves
  • Effect of mannan oligosaccharides supplemented via milk replacer on the immune status and growth of calves (en)
  • Vliv oligosacharidů mannanů podávaných v mléčné náhražce na imunitu a užitkovost telat (cs)
skos:notation
  • RIV/62157124:16170/06:00000287!RIV07-MZE-16170___
http://linked.open.../vavai/riv/strany
  • 1
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • P(1B44035)
http://linked.open...iv/cisloPeriodika
  • 1
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 473120
http://linked.open...ai/riv/idVysledku
  • RIV/62157124:16170/06:00000287
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • calves, milk replacer, mannan oligosaccharides, immunoglobulines (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • SI - Slovinská republika
http://linked.open...ontrolniKodProRIV
  • [E52B50A595FE]
http://linked.open...i/riv/nazevZdroje
  • Slovenian Veterinary Research
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...vavai/riv/projekt
http://linked.open...UplatneniVysledku
http://linked.open...iv/tvurceVysledku
  • Illek, Josef
  • Kumprechtová, Dana
issn
  • 1580-4003
number of pages
http://localhost/t...ganizacniJednotka
  • 16170
is http://linked.open...avai/riv/vysledek of
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 58 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software